We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
276
Clearstead Advisors
Ohio
$13 -$2.28K -199 -100%
Walleye Capital
277
Walleye Capital
New York
– -$8M -798,870 Closed
Connor, Clark & Lunn Investment Management (CC&L)
278
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$6.24M -623,258 Closed
CM
279
Capula Management
Cayman Islands
– -$1.45M -145,300 Closed
DB
280
Danske Bank
Denmark
– -$1.09M -109,121 Closed
ACM
281
Aquatic Capital Management
Illinois
– -$877K -87,588 Closed
Zurich Cantonal Bank
282
Zurich Cantonal Bank
Switzerland
– -$762K -66,555 Closed
VI
283
Versor Investments
New York
– -$578K -57,700 Closed
EWM
284
Empirical Wealth Management
Washington
– -$449K -44,829 Closed
PTC
285
Petrus Trust Company
Texas
– -$360K -35,962 Closed
WG
286
Winton Group
United Kingdom
– -$304K -30,415 Closed
AC
287
AXQ Capital
New Jersey
– -$233K -23,254 Closed
OAC
288
OMERS Administration Corp
Ontario, Canada
– -$219K -21,900 Closed
Capstone Investment Advisors
289
Capstone Investment Advisors
New York
– -$168K -16,762 Closed
PCM
290
Prelude Capital Management
New York
– -$138K -13,801 Closed
CAPTRUST Financial Advisors
291
CAPTRUST Financial Advisors
North Carolina
– -$121K -12,048 Closed
ASN
292
Advisory Services Network
Georgia
– -$50.2K -5,015 Closed
Focus Partners Wealth
293
Focus Partners Wealth
Massachusetts
– -$242K -4,203 Closed
PS
294
Principal Securities
Iowa
– -$21.7K -2,170 Closed
QL
295
Quarry LP
New York
– -$12.1K -1,212 Closed
Northwestern Mutual Wealth Management
296
Northwestern Mutual Wealth Management
Wisconsin
– -$1.55K -155 Closed
GLF
297
Groupe la Francaise
France
– -$1.26K -150 Closed
GWSG
298
GPS Wealth Strategies Group
Colorado
– -$1.15K -115 Closed
CMBA
299
C.M. Bidwell & Associates
Hawaii
– -$651 -65 Closed
WANY
300
Wealthspire Advisors (New York)
New York
– -$240 -24 Closed
8 9 10 11
12

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.